Adjuvant chemotherapy of megestrol acetate in advanced breast cancer: A meta-analysis

Authors

  • Yanping Shui Wannan Medical College, Wuhu, Anhui, 241001
  • Youmei Tang Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 64100
  • Xuefeng Zhang Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 64100
  • Jun Ge Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 64100
  • Zhichen Pu Institute of Drug Clinical Evaluation ,Yijishan Hospital , Wannan Medical College, Wuhu, Anhui, 241001

DOI:

https://doi.org/10.3329/bjp.v10i2.22275

Keywords:

Megestrol acetate, Adjuvant chemotherapy, Breast cancer, Randomized controlled trial, Meta-analysis

Abstract

To evaluate the effectiveness and safety of adjuvant chemotherapy of megestrol acetate (MA) in advanced breast cancer, we searched CBM, CNKI, VIP, Wangfang Data and PubMed, and collected randomized controlled trials (RCT) of adjuvant chemotherapy of MA in advanced breast cancer. MA significantly increased treatment efficiency (p=0.0010); improve weight (p<0.0001), appetite (p=0.001) and KPS (p=0.06); ameliorate leucopenia (p=0.02), thrombocytopenia (p=0.02) and hemoglobin (p=0.01); reduce gastrointestinal reaction (p=0.0005) of the patients of adjuvant chemotherapy in advanced breast cancer. MA significantly increased treatment efficiency, improve the nutritional situation, reduce bone marrow suppression, and gastrointestinal reaction of the patients of adjuvant chemotherapy in advanced breast cancer. High-quality RCTs are needed to guidance for preliminary studies of the effective treatment of adjuvant chemotherapy of MA in advanced breast cancer.  

Downloads

Download data is not yet available.
Abstract
586
Download
327 Read
188

Downloads

Additional Files

Published

2015-04-24

How to Cite

Shui, Y., Y. Tang, X. Zhang, J. Ge, and Z. Pu. “Adjuvant Chemotherapy of Megestrol Acetate in Advanced Breast Cancer: A Meta-Analysis”. Bangladesh Journal of Pharmacology, vol. 10, no. 2, Apr. 2015, pp. 383-92, doi:10.3329/bjp.v10i2.22275.

Issue

Vol. 10 No. 2 (2015)

Section

Meta-Analysis

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).